vs
Axos Financial, Inc.（AX）与Axsome Therapeutics, Inc.（AXSM）财务数据对比。点击上方公司名可切换其他公司
Axos Financial, Inc.的季度营收约是Axsome Therapeutics, Inc.的2.0倍（$392.2M vs $196.0M），Axos Financial, Inc.净利率更高（31.8% vs -14.6%，领先46.4%），过去两年Axsome Therapeutics, Inc.的营收复合增速更高（61.7% vs 16.1%）
Axos Financial是总部位于美国内华达州拉斯维加斯的银行控股公司，旗下拥有直销银行Axos Bank，同时提供注册投资顾问服务及电子交易平台，深耕数字化金融赛道，可为用户提供多元便捷的金融服务解决方案。
Jazz Pharmaceuticals是一家全球生物制药企业，专注于肿瘤学与神经科学领域的药物研发及商业化。公司2003年在美国加利福尼亚州成立，目前总部位于爱尔兰都柏林，业务覆盖全球多个核心市场。
AX vs AXSM — 直观对比
营收规模更大
AX
是对方的2.0倍
$196.0M
净利率更高
AX
高出46.4%
-14.6%
两年增速更快
AXSM
近两年复合增速
16.1%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $392.2M | $196.0M |
| 净利润 | $124.7M | $-28.6M |
| 毛利率 | — | — |
| 营业利润率 | — | -13.8% |
| 净利率 | 31.8% | -14.6% |
| 营收同比 | — | 65.0% |
| 净利润同比 | 18.5% | 61.9% |
| 每股收益（稀释后） | $2.15 | $-0.55 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXAXSM
| Q1 26 | $392.2M | — | ||
| Q4 25 | $385.1M | $196.0M | ||
| Q3 25 | $323.4M | $171.0M | ||
| Q2 25 | $321.4M | $150.0M | ||
| Q1 25 | $308.8M | $121.5M | ||
| Q4 24 | $307.9M | $118.8M | ||
| Q3 24 | $320.7M | $104.8M | ||
| Q2 24 | $290.9M | $87.2M |
净利润AXAXSM
| Q1 26 | $124.7M | — | ||
| Q4 25 | $128.4M | $-28.6M | ||
| Q3 25 | $112.4M | $-47.2M | ||
| Q2 25 | $110.7M | $-48.0M | ||
| Q1 25 | $105.2M | $-59.4M | ||
| Q4 24 | $104.7M | $-74.9M | ||
| Q3 24 | $112.3M | $-64.6M | ||
| Q2 24 | $104.9M | $-79.3M |
营业利润率AXAXSM
| Q1 26 | — | — | ||
| Q4 25 | 45.6% | -13.8% | ||
| Q3 25 | 46.3% | -27.0% | ||
| Q2 25 | 48.5% | -24.5% | ||
| Q1 25 | 47.9% | -46.9% | ||
| Q4 24 | 48.8% | -61.1% | ||
| Q3 24 | 49.6% | -59.8% | ||
| Q2 24 | 49.6% | -89.5% |
净利率AXAXSM
| Q1 26 | 31.8% | — | ||
| Q4 25 | 33.3% | -14.6% | ||
| Q3 25 | 34.7% | -27.6% | ||
| Q2 25 | 34.4% | -32.0% | ||
| Q1 25 | 34.1% | -48.9% | ||
| Q4 24 | 34.0% | -63.1% | ||
| Q3 24 | 35.0% | -61.7% | ||
| Q2 24 | 36.0% | -91.0% |
每股收益（稀释后）AXAXSM
| Q1 26 | $2.15 | — | ||
| Q4 25 | $2.22 | $-0.55 | ||
| Q3 25 | $1.94 | $-0.94 | ||
| Q2 25 | $1.89 | $-0.97 | ||
| Q1 25 | $1.81 | $-1.22 | ||
| Q4 24 | $1.80 | $-1.54 | ||
| Q3 24 | $1.93 | $-1.34 | ||
| Q2 24 | $1.75 | $-1.67 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $322.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $3.1B | $88.3M |
| 总资产 | $29.2B | $689.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AXAXSM
| Q1 26 | — | — | ||
| Q4 25 | $1.0B | $322.9M | ||
| Q3 25 | $2.6B | $325.3M | ||
| Q2 25 | $1.9B | $303.0M | ||
| Q1 25 | $2.0B | $300.9M | ||
| Q4 24 | $2.4B | $315.4M | ||
| Q3 24 | $2.6B | $327.3M | ||
| Q2 24 | $2.0B | $315.7M |
总债务AXAXSM
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $312.7M | — | ||
| Q1 25 | $377.4M | — | ||
| Q4 24 | $358.7M | — | ||
| Q3 24 | $313.5M | — | ||
| Q2 24 | $325.7M | — |
股东权益AXAXSM
| Q1 26 | $3.1B | — | ||
| Q4 25 | $2.9B | $88.3M | ||
| Q3 25 | $2.8B | $73.7M | ||
| Q2 25 | $2.7B | $73.1M | ||
| Q1 25 | $2.6B | $53.2M | ||
| Q4 24 | $2.5B | $57.0M | ||
| Q3 24 | $2.4B | $92.9M | ||
| Q2 24 | $2.3B | $102.9M |
总资产AXAXSM
| Q1 26 | $29.2B | — | ||
| Q4 25 | $28.2B | $689.8M | ||
| Q3 25 | $27.4B | $669.3M | ||
| Q2 25 | $24.8B | $639.8M | ||
| Q1 25 | $24.0B | $596.7M | ||
| Q4 24 | $23.7B | $568.5M | ||
| Q3 24 | $23.6B | $561.5M | ||
| Q2 24 | $22.9B | $548.2M |
负债/权益比AXAXSM
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.14× | — | ||
| Q4 24 | 0.14× | — | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | 0.14× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-18.7M |
| 自由现金流经营现金流 - 资本支出 | — | $-18.7M |
| 自由现金流率自由现金流/营收 | — | -9.6% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-93.9M |
8季度趋势，按日历期对齐
经营现金流AXAXSM
| Q1 26 | — | — | ||
| Q4 25 | $104.1M | $-18.7M | ||
| Q3 25 | $118.4M | $1.0M | ||
| Q2 25 | $490.3M | $-32.4M | ||
| Q1 25 | $73.7M | $-43.4M | ||
| Q4 24 | $162.5M | $-26.2M | ||
| Q3 24 | $70.8M | $-18.6M | ||
| Q2 24 | $305.5M | $-30.1M |
自由现金流AXAXSM
| Q1 26 | — | — | ||
| Q4 25 | $85.4M | $-18.7M | ||
| Q3 25 | $109.3M | $988.0K | ||
| Q2 25 | $436.1M | $-32.4M | ||
| Q1 25 | $65.1M | $-43.7M | ||
| Q4 24 | $156.4M | $-26.2M | ||
| Q3 24 | $53.0M | $-18.7M | ||
| Q2 24 | $269.5M | $-30.2M |
自由现金流率AXAXSM
| Q1 26 | — | — | ||
| Q4 25 | 22.2% | -9.6% | ||
| Q3 25 | 33.8% | 0.6% | ||
| Q2 25 | 135.7% | -21.6% | ||
| Q1 25 | 21.1% | -36.0% | ||
| Q4 24 | 50.8% | -22.1% | ||
| Q3 24 | 16.5% | -17.9% | ||
| Q2 24 | 92.6% | -34.6% |
资本支出强度AXAXSM
| Q1 26 | — | — | ||
| Q4 25 | 4.9% | 0.0% | ||
| Q3 25 | 2.8% | 0.0% | ||
| Q2 25 | 16.9% | 0.0% | ||
| Q1 25 | 2.8% | 0.3% | ||
| Q4 24 | 2.0% | 0.0% | ||
| Q3 24 | 5.5% | 0.1% | ||
| Q2 24 | 12.4% | 0.1% |
现金转化率AXAXSM
| Q1 26 | — | — | ||
| Q4 25 | 0.81× | — | ||
| Q3 25 | 1.05× | — | ||
| Q2 25 | 4.43× | — | ||
| Q1 25 | 0.70× | — | ||
| Q4 24 | 1.55× | — | ||
| Q3 24 | 0.63× | — | ||
| Q2 24 | 2.91× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AX
| Net Interest Income | $306.3M | 78% |
| Noninterest Income | $86.0M | 22% |
AXSM
暂无分部数据
